Psychedelics have demonstrated significant progress, generating enthusiasm across the neuroscience industry and leading to ...

Layoffs are looming in Switzerland as Novartis announces its plans to cut upwards of 550 full-time positions by the end of ...

Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to support financial flexibility and ...

Businesses want to be available to provide for employees and be competitive. They want workers to be able to go to the HR ...

Psychedelics have demonstrated significant progress, with promising data and increased interest from large companies, ...

Tesaro confirmed its litigation against AnaptysBio in the Delaware Chancery Court in a press release on its website, ...

Aidoc's multi-triage device, powered by the CARE Foundation Model, detects and prioritizes multiple abdominal conditions with ...

Moderna's $140 million investment in Norwood, Massachusetts, aims to complete its U.S. manufacturing loop, enhancing ...

Johnson & Johnson acquires Halda Therapeutics for $3 billion to strengthen its oncology portfolio, focusing on prostate ...

Regeneron announced the FDA’s approval of two indications of Eylea HD, including an 8mg injection for patients with macular ...

Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings Institution, continues his conversation about ...

In today’s Pharmaceutical Executive Daily, learn how Tesaro is suing AnaptysBio over alleged contract breaches, Flagship ...